Skip to content

CNO Financial Group CNO Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Globe Life logo
Globe LifeGL
UnitedHealth Group logo
UnitedHealth GroupUNH
MetLife logo
MetLifeMET
Voya Financial logo
Voya FinancialVOYA
Fidelity National Financial logo
Fidelity National FinancialFNF
CNA Financial logo
CNA FinancialCNA

Other financials

Income statement

See full
Revenue$1.0B+2.5%
Net income$37.7M+75.3%
EPS (diluted)$0.39+85.7%

Balance sheet

See full
Cash & equivalents$1.2B+12.6%
Total debt$1.4B-41.0%
Total equity$2.5B-2.2%
Total assets$39.0B+4.1%

Cash flow

See full
Operating cash flow$148.8M+8.9%

Valuation

See full
Market cap$4.74B-7.9%

Profitability

See full
Net margin5.4%-2.2pp

Returns & leverage

See full
Return on equity9.7%-3.7pp
Debt / equity0.5×-0.4×

Where this comes from

Reported directly by CNO Financial Group in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: CNO Financial Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CNO Financial Group's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CNO Financial Group's common stock, shares authorized (in shares)?
CNO Financial Group (CNO) reported common stock, shares authorized (in shares) of $8B in Q1 2026.
How has CNO Financial Group's common stock, shares authorized (in shares) changed year-over-year?
CNO Financial Group's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $8B to $8B.
What is the long-term trend for CNO Financial Group's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), CNO Financial Group's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $8B to $8B.